RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that certain officers and directors of the Company have adopted predetermined trading plans to exercise expiring stock options over time in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, and with Salix’ policies regarding stock transactions and ownership. Rule 10b5-1 allows corporate officers and directors to adopt written, pre-arranged stock trading plans when they do not have material, non-public information.
